The study was led by Prof. Yuval Ebenstein of the School of Chemistry at the Faculty of Exact Sciences, the Department of Biomedical Engineering and the Zimin Institute at Tel Aviv University, in collaboration with researchers from JaxBio Technologies, Bnai Zion Medical Center and Sheba Medical Center. The paper is published in the journal npj Precision Oncology.

A different approach to lung cancer detection

Lung cancer is the leading cause of cancer-related death worldwide. At present, early diagnosis relies primarily on CT scans, but these tests generate a high rate of suspicious findings that ultimately prove to be benign, sometimes leading to unnecessary biopsies and surgeries. At the same time, existing liquid biopsies are generally based on DNA sequencing, a costly and complex process requiring advanced computational infrastructure.